SCH Investment Partners LLC

Insider profile

SCH Investment Partners LLC's trades of Royalty Pharma PLC's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
292.57
Quantity 32,620
Value US$3,247,100
Transaction date
Proposed sale
Price
385.36
Quantity 98,529
Value US$4,310,492
Transaction date
Proposed sale
Price
382.53
Quantity 41,035
Value US$2,977,466
Transaction date
Proposed sale
Price
54.45
Quantity 150,000
Value US$8,166,766
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-22 2026-09-22 PrS Proposed sale
32,620
292.57
US$3,247,100
32,620 292.57 US$3,247,100
2026-08-18 2026-08-18 PrS Proposed sale
98,529
385.36
US$4,310,492
98,529 385.36 US$4,310,492
2026-07-01 2026-06-30 PrS Proposed sale
41,035
382.53
US$2,977,466
41,035 382.53 US$2,977,466
2026-06-23 2026-06-23 PrS Proposed sale
150,000
54.45
US$8,166,766
150,000 54.45 US$8,166,766